Nebulized Dexmedetomidine Versus Neostigmine/Atropine in Postdural Puncture Headache

• Status: Completed
• Trial end date: 2021-09-03
• Target enrollment: 0
• Participant gender: Female

Summary

In our study, we will compare a new route of nebulization for effectiveness between dexmedetomidine, neostigmine/atropine and saline placebo for females complained of postdural puncture headache (PDPH) after cesarean section.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Atropine; Dexmedetomidine; Neostigmine

Criteria

Inclusion Criteria:

• Clinical diagnosis of postdural puncture headache (PDPH) after elective cesarean section under spinal anesthesia.

Exclusion Criteria:

• Hypersensitivity of dexmedetomidine, neostigmine or atropine

• Overactive thyroid gland

• Myasthenia gravis

• Closed angle glaucoma

• High blood pressure and coronary artery disease.

• withdrawal of consent